Colossal Biosciences
Edit

Colossal Biosciences

https://colossal.com/
Last activity: 25.08.2026
Active
Categories: AIAvianBioengineeringBiotechnologyConservationDeepTechDeExtinctionDe-extinctionGeneticEngineeringGeneticsGenomics
The science of genetics. The business of discovery.

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth. Colossal is accepting humanity’s duty to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition through cutting-edge science and technologies.
Likes
248
Followers
4.91K
Followers
3.36K
Website visits
21.5K /mo.
Mentions
122
Location: United States
Employees: 51-200
Total raised: $805M
Valuation: $10.32B
Founded date: 2021

Investors 10

Funding Rounds 6

DateSeriesAmountInvestors
10.11.2025Series C$320MARCH Ventu...
17.01.2025Series C$200M-
02.02.2023Series B$150MPEAK6 Inve...
17.01.2023Series A$60M-
09.03.2022Series A$60M-
13.09.2021-$15M-

Mentions in press and media 122

DateTitleDescription
25.08.2026Can the Capital Access Window finally revive AIM?August is usually a sleepy time for capital markets. Investors head off on their summer jaunts, firms take a breath after a frenzy of results in late July and advisors start mapping out back-to-school plans for September. Not so in the worl...
24.08.2026Astromech Secures $20 Million to Pioneer Predictive AI Biology, Valued at $3.8 BillionAstromech, a cutting-edge computational biology firm, recently secured $20 million in funding. This capital injection propels its mission: to forecast biological evolution using advanced AI. The company aims to predict how living systems ch...
21.08.2026Astromech Raises $20 Million To Build AI Biology That Forecasts Evolutionary ChangesFor most of science, biology has been reactive. A disease first emerges before a genome sequence follows. A species is first lost before there’s an extinction study. Astromech raises $20 million to train AI models that can predict how livin...
21.08.2026Astromech Raises $20M in FundingAstromech, a Dallas, TX-based computational biology and predictive artificial intelligence startup spun out from de-extinction company Colossal Biosciences, raised $20m in funding. The round was led by Bob Nelsen (co-founder of ARCH Venture...
20.08.2026Astromech Raises $20 Million At $3.8 Billion Valuation To Advance Predictive AI Models Of Biological Evolutionary ChangeAstromech, an evolutionary biology AI company developing predictive models of biological change using evolutionary and multispecies genomic data, has raised $20 million in new funding at a $3.8 billion valuation. Biotech investor Bob Nelsen...
21.07.2026Colossal Biosciences punta a 30 miliardiColossal Biosciences sarebbe in trattativa per raccogliere nuovi capitali a una valutazione compresa tra 20 e 30 miliardi di dollari. A riportarlo è Axios, che non ha indicato né il potenziale lead investor né l’ammontare complessivo del ro...
01.07.2026Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene EditingThe collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmania DALLAS and HOBART, Australia...
10.06.2026Animal Capital Raises $33 Million Fund III To Expand Early-Stage Investment StrategyAnimal Capital announced the closing of Animal Capital Fund III with $33 million in total commitments, marking a significant increase from its previous funds and enabling the firm to expand its focus on early-stage investments. The new fund...
06.06.2026Без скорлупы и наседок: новая технология может вернуть на Землю дронтов и моаУченые уже давно ищут способы вернуть в природу животных, исчезнувших по вине человека. Самое интересное, что, помимо теоретических статей, в последнее время появились реальные практические проекты. Один из самых интересных — у компании Col...
22.05.2026Chicks hatch from artificial egg as US company aims to revive extinct speciesPrevious An artificial egg platform developed by Colossal Biosciences at a laboratory at the company's headquarters in Dallas, Texas, U.S., in this undated photograph released May 19, 2026. Colossal Biosciences/Handout via REUTERS A chick n...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In